<<Prev Rule

Texas Administrative Code

Next Rule>>
TITLE 22EXAMINING BOARDS
PART 15TEXAS STATE BOARD OF PHARMACY
CHAPTER 291PHARMACIES
SUBCHAPTER BCOMMUNITY PHARMACY (CLASS A)
RULE §291.33Operational Standards

      (xi) either on the prescription label or the written information accompanying the prescription, the statement "Do not flush unused medications or pour down a sink or drain." A drug product on a list developed by the Federal Food and Drug Administration of medicines recommended for disposal by flushing is not required to bear this statement; and

      (xii) any other information, statements, or warnings required for any of the drug products contained therein.

    (B) If the patient med-pak allows for the removal or separation of the intact containers therefrom, each individual container shall bear a label identifying each of the drug product contained therein.

    (C) The dispensing container is not required to bear the label as specified in subparagraph (A) of this paragraph if:

      (i) the drug is prescribed for administration to an ultimate user who is institutionalized in a licensed health care institution (e.g., nursing home, hospice, hospital);

      (ii) no more than a 90-day supply is dispensed at one time;

      (iii) the drug is not in the possession of the ultimate user prior to administration;

      (iv) the pharmacist-in-charge has determined that the institution:

        (I) maintains medication administration records which include adequate directions for use for the drug(s) prescribed;

        (II) maintains records of ordering, receipt, and administration of the drug(s); and

        (III) provides for appropriate safeguards for the control and storage of the drug(s); and

      (v) the dispensing container bears a label that adequately:

        (I) identifies the:

          (-a-) pharmacy by name and address;

          (-b-) name of the patient; and

          (-c-) name and strength of each drug product dispensed;

          (-d-) name of the patient; and

          (-e-) name of the prescribing practitioner of each drug product, or the pharmacist who signed the prescription drug order;

        (II) the date after which the prescription should not be used or beyond-use-date. Unless otherwise specified by the manufacturer, the beyond-use-date shall be one year from the date the med-pak is dispensed or the earliest manufacturer's expiration date for a product contained in the med-pak if it is less than one-year from the date dispensed. The beyond-use-date may be placed on the prescription label or on a flag label attached to the bottle. A beyond-use-date is not required on the label of a prescription dispensed to a person at the time of release from prison or jail if the prescription is for not more than a 10-day supply of medication; and

        (III) for each drug product sets forth the directions for use and cautionary statements, if any, contained on the prescription drug order or required by law.

  (3) Labeling. The patient med-pak shall be accompanied by a patient package insert, in the event that any drug contained therein is required to be dispensed with such insert as accompanying labeling. Alternatively, such required information may be incorporated into a single, overall educational insert provided by the pharmacist for the total patient med-pak.

  (4) Packaging. In the absence of more stringent packaging requirements for any of the drug products contained therein, each container of the patient med-pak shall comply with official packaging standards. Each container shall be either not reclosable or so designed as to show evidence of having been opened.

  (5) Guidelines. It is the responsibility of the dispensing pharmacist when preparing a patient med-pak, to take into account any applicable compendial requirements or guidelines and the physical and chemical compatibility of the dosage forms placed within each container, as well as any therapeutic incompatibilities that may attend the simultaneous administration of the drugs.

  (6) Recordkeeping. In addition to any individual prescription filing requirements, a record of each patient med-pak shall be made and filed. Each record shall contain, as a minimum:

    (A) the name and address of the patient;

    (B) the unique identification number for the patient med-pak itself and a separate unique identification number for each of the prescription drug orders for each of the drug products contained therein;

    (C) the name of the manufacturer or distributor and lot number for each drug product contained therein;

    (D) information identifying or describing the design, characteristics, or specifications of the patient med-pak sufficient to allow subsequent preparation of an identical patient med-pak for the patient;

    (E) the date of preparation of the patient med-pak and the beyond-use date that was assigned;

    (F) any special labeling instructions; and

    (G) the initials or an identification code of the dispensing pharmacist.

  (7) The patient med-pak label is not required to include the initials or identification code of the dispensing pharmacist as specified in paragraph (2)(A) of this subsection if the identity of the dispensing pharmacist is recorded in the pharmacy's data processing system. The record of the identity of the dispensing pharmacist shall not be altered in the pharmacy's data processing system.

(i) Automated devices and systems.

  (1) Automated compounding or counting devices. If a pharmacy uses automated compounding or counting devices:

    (A) the pharmacy shall have a method to calibrate and verify the accuracy of the automated compounding or counting device and document the calibration and verification on a routine basis;

    (B) the devices may be loaded with bulk or unlabeled drugs only by a pharmacist or by pharmacy technicians or pharmacy technician trainees under the direction and direct supervision of a pharmacist;

    (C) the label of an automated compounding or counting device container shall indicate the brand name and strength of the drug; or if no brand name, then the generic name, strength, and name of the manufacturer or distributor;

    (D) records of loading bulk or unlabeled drugs into an automated compounding or counting device shall be maintained to show:

      (i) name of the drug, strength, and dosage form;

      (ii) manufacturer or distributor;

      (iii) manufacturer's lot number;

      (iv) manufacturer's expiration date;

      (v) date of loading;

      (vi) name, initials, or electronic signature of the person loading the automated compounding or counting device; and

      (vii) signature or electronic signature of the responsible pharmacist; and

    (E) the automated compounding or counting device shall not be used until a pharmacist verifies that the system is properly loaded and affixes his or her signature to the record as specified in subparagraph (D) of this paragraph.

  (2) Automated pharmacy dispensing systems.

    (A) Authority to use automated pharmacy dispensing systems. A pharmacy may use an automated pharmacy dispensing system to fill prescription drug orders provided that:

      (i) the pharmacist-in-charge is responsible for the supervision of the operation of the system;

      (ii) the automated pharmacy dispensing system has been tested by the pharmacy and found to dispense accurately. The pharmacy shall make the results of such testing available to the board upon request; and

      (iii) the pharmacy will make the automated pharmacy dispensing system available for inspection by the board for the purpose of validating the accuracy of the system.

    (B) Quality assurance program. A pharmacy which uses an automated pharmacy dispensing system to fill prescription drug orders shall operate according to a written program for quality assurance of the automated pharmacy dispensing system which:

      (i) requires continuous monitoring of the automated pharmacy dispensing system; and

      (ii) establishes mechanisms and procedures to test the accuracy of the automated pharmacy dispensing system at least every six months and whenever any upgrade or change is made to the system and documents each such activity.

    (C) Policies and procedures of operation.

      (i) When an automated pharmacy dispensing system is used to fill prescription drug orders, it shall be operated according to written policies and procedures of operation. The policies and procedures of operation shall:

        (I) provide for a pharmacist's review, approval, and accountability for the transmission of each original or new prescription drug order to the automated pharmacy dispensing system before the transmission is made;

Cont'd...

Next Page Previous Page

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page